相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence of and survival following brain metastases among women with inflammatory breast cancer
S. Dawood et al.
ANNALS OF ONCOLOGY (2010)
LOCOREGIONAL OUTCOMES OF INFLAMMATORY BREAST CANCER PATIENTS TREATED WITH STANDARD FRACTIONATION RADIATION AND DAILY SKIN BOLUS IN THE TAXANE ERA
Shari Damast et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Locoregional treatment outcomes after multimodality management of inflammatory breast cancer
Ian J. Bristol et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Taxane-based combinations as adjuvant chemotherapy of early breast cancer: A meta-analysis of randomized trials
Michele De Laurentiis et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The role of locoregional therapy in inflammatory breast cancer
Wendy A. Woodward et al.
SEMINARS IN ONCOLOGY (2008)
Inflammatory breast cancer (IBC) and patterns of recurrence - Understanding the biology of a unique disease
Massimo Cristofanilli et al.
CANCER (2007)
Lack of uniform diagnostic criteria for inflammatory breast cancer limits interpretation of treatment outcomes: A systematic review
Theodore Kim et al.
CLINICAL BREAST CANCER (2006)
Impact of a scientific presentation on community treatment patterns for primary breast cancer
SH Giordano et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer
SB Wedam et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute
KW Hance et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Evolving treatment strategies for inflammatory breast cancer: A population-based survival analysis
M Panades et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High incidence of HER-2 positivity in inflammatory breast cancer
M Parton et al.
BREAST (2004)
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy
F Bertucci et al.
CANCER RESEARCH (2004)
Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy
JA Low et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
IC Henderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression
CG Colpaert et al.
BRITISH JOURNAL OF CANCER (2003)
Locoregional irradiation for inflammatory breast cancer: Effectiveness of dose escalation in decreasing recurrence
ZX Liao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
